Technology | Mammography | March 27, 2018

Siemens Healthineers Announces FDA Clearance of Mammomat Revelation Mammography System

3-D HD Breast Biopsy enables more targeted, accurate biopsies; automated breast density measurement allows immediate risk stratification at the point of care

Siemens Healthineers Announces FDA Clearance of Mammomat Revelation Mammography System

March 27, 2018 — The U.S. Food and Drug Administration (FDA) has cleared Siemens Healthineers’ Mammomat Revelation premium mammography platform with the new InSpect integrated specimen imaging tool and the new HD Breast Biopsy solution for one-click targeting of suspicious areas. These and other features are designed to expand precision medicine and improve the patient experience.

Mammomat Revelation’s InSpect integrated specimen imaging tool permits imaging and real-time review of biopsy samples at the workstation. This tool improves biopsy workflow, shortens compression time and reduces patient discomfort.

HD Breast Tomosynthesis offers the widest image acquisition angle available at 50 degrees, according to Siemens. The wide angle delivers what the company calls the industry’s highest depth resolution for better separation of overlapping breast tissue, providing high-quality 3-D images for improved diagnostic confidence and earlier lesion detection. This technology is the basis for Mammomat Revelation’s HD Breast Biopsy solution, which enables one-click targeting of suspicious areas with a +/- 1mm accuracy.

Nearly half of all women in the United States who receive mammograms have dense breasts,¹ complicating efforts to identify breast lesions. Typically, the radiologist assesses fibroglandular breast density visually after the patient has left the facility. Mammomat Revelation is the first platform to offer automated breast density measurement during the mammogram for immediate, personalized risk stratification and more personalized care.

Mammomat Revelation’s Personalized Soft Compression adjusts the level of breast compression automatically to suit each patient’s anatomy.  Coupled with ergonomic SoftComp Paddles, Personalized Soft Compression enables improved breast positioning, more consistent image quality, and less discomfort and anxiety.

And for inconclusive cases, the system offers titanium contrast-enhanced mammography as a cost-effective alternative to magnetic resonance imaging (MRI), reducing scheduling conflicts and reassuring the patient.

For more information: www.usa.healthcare.siemens.com

References

1. National Cancer Institute, https://www.cancer.gov/types/breast/breast-changes/dense-breasts

Related Content

RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Lunit Announces New Prominent Radiology Advisory Board Members
News | Artificial Intelligence | December 11, 2018
Medical artificial intelligence (AI) software company Lunit announced three new members of its advisory board,...
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Videos | Advanced Visualization | November 30, 2018
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at t
Videos | Digital Radiography (DR) | November 30, 2018
This is an example of moving X-ray images displayed by Konica Minolta today at the...